Date & Time
Tuesday, November 2, 2021, 8:15 AM - 9:15 AM
435 Clozapine for Treatment-Resistant Psychosis and Self-Injurious Behavior: Why and How to Expand Use in Your State*

Clozapine is the only medication approved for treatment-resistant schizophrenia and suicide prevention yet is markedly underused in prison systems. There is also an emerging evidence base from prisons showing that clozapine reduces self-injurious behavior, aggression, infractions, and time assigned to disciplinary segregation. This presentation will review clozapine's benefits, discuss barriers to use in corrections, and present practical solutions on how to expand use in a prison system.

Educational Objectives:

List three potential benefits of clozapine use in correctional settings

Identify three barriers to clozapine use in correctional systems

Describe the mechanics of a clozapine consultative system and how this may help expand prescribing

Level: Intermediate

Mental Health